Fogorvosi szemle, 2020 (113. évfolyam, 1-4. szám)

2020-03-01 / 1. szám

FOGORVOSI SZEMLE

113. évf. 1. sz. 2020.n

7

4. DE OLIVEIRA FA, DUARTE EC, TAVEIRA CT, MÁXIMO AA, DE AQUINO EC, ALENCAR RDE C, et al:

Salivary Gland Tumor: A Review of 599 Cases in a Brazilian Population. Head Neck Pathol

2009; 3 (4): 271–275. https://doi.org/10.1007/s12105-009-0139-9

5. GAO M, HAO Y, HUANG MX, MA DQ, CHEN Y, LUO HY, et al:

Salivary gland tumours in a northern Chinese population: a 50-year retrospective study of 7190 cases. Int J Oral Maxillofac Surg

2017; 46 (3): 343–349. https://doi.org/10.1016/j.ijom.2016.09.021

6. HUPP J, TUCKER M, ELLIS E: Contemporary Oral and Maxillofa

cial Surgery. (6th ed.) Elsevier Mosby, St. Louis, 2014; 415–419.

7. JAAFARI-ASHKAVANDI Z, ASHRAF MJ, MOSHAVERINIA M: Salivary gland tumors: a clinicopathologic study of 366 cases in southern Iran. Asian Pac J Cancer Prev 2013; 14 (1): 27–30. https://doi.org/10.7314/

APJCP.2013.14.1.27

8. JONES AV, CRAIG GT, SPEIGHT PM, FRANKLIN CD: The range and demographics of salivary gland tumours diagnosed in a UK population. Oral Oncol

2008; 44 (4): 407–417. https://doi.org/10.1016/j.

oraloncology.2007.05.010

9. Lukšić i, Virag M, MaNojLoVić s, MaCaN D: Salivary gland tumours: 25 years of experience from a single institution in Croatia. J Cranio-Maxillofacial Surg 2012; 40 (3): e75–e81. https://doi.

org/10.1016/j.jcms.2011.05.002

10. MACHTENS E: Speicheldrüsenerkrankungen. Mund Kiefer Ge

schichtsChir 2000; 4 (1): 401–413. https://doi.org/10.1007/

PL00014564

11. MEJÍA-VELÁZQUEZ CP, DURÁN-PADILLA MA, GÓMEZ-APO E, QUEZADARIVERA D, GAITÁN-CEPEDA LA: Tumors of the salivary gland in Mexicans. A retrospective study of 360 cases. Med Oral Patol Oral Cir Bucal 2012; 17 (2): e183–189. https://doi.org/10.4317/

medoral.17434

12. MILORO M, GHALI GE, LARSEN PE, WAITE PD: Peterson’s Principles of oral and maxillofacial surgery. (2nd ed.) BC Decker, London, 2004; 671–677.

13. OCHICHA O, MALAMI S, MOHAMMED A, ATANDA A: A histopathologic study of salivary gland tumors in Kano, northern Nigeria. Indian J Pathol Microbiol 2009; 52: 473–476. https://doi.org/10.4103/0377-4929.56121

14. OMITOLA OG, SOYELE OO, BUTALI A, AKINSHIPO AO, OKOH D, SIGBEKU O, et al:

Descriptive epidemiology of salivary gland neoplasms in Nigeria: An AOPRC multicenter tertiary hospital study. Oral Dis

2018; 25 (1): 142–149. https://doi.org/10.1111/odi.12956

15. SANDO Z, FOKOUO JV, MEBADA AO, DJOMOU F, NDJOLO A, OYONO JL: Epidemiological and histopathological patterns of salivary gland tumors in Cameroon. Pan Afr Med J

2016; 23: 66. https://doi.

org/10.11604/pamj.2016.23.66.5105

16. SATKO I, STANKO P, LONGAUEROVÁ I: Salivary gland tumours treated in the stomatological clinics in Bratislava. J Craniomaxillofac Surg

2000; 28 (1): 56–61. https://doi.org/10.1054/jcms.1999.0092

17. SHAH J, PATEL S, SINGH B: Jatin Shah’s Head and Neck Surgery and Oncology. (4th ed.) Elsevier, Philadelphia, 2012; 526–528.

18. SUBA ZS: Orális és maxillofaciális patológia. Medicina, Budapest, 2011; 365–367.

19. SUBA ZS, BARABÁS J, TAKÁCS D, SZABÓ GY, UJPÁL M: Az inzulinrezisztencia és a nyálmirigydaganatok epidemiológiai összefüggései. Orv Hetil 2005; 146 (33): 1727–1732. https://doi.org/10.2307/

25434163

20. TAGHAVI N, SARGOLZAEI S, MASHHADIABBAS F, AKBARZADEH A, KARDOUNI P: Salivary gland tumors: a 15-year report from Iran. Turkish J Pathol 2015; 32 (1): 35–39. https://doi.org/10.5146/tjpath.2015.01336

21. https://www.who.int/countries/cmr/en/ (2019.05.08.)

NÉMETH V, NÉMETH ZS, UJPÁL M

The worldwide epidemiology of salivary gland tumors

Salivary gland tumors cannot be classified as frequent tumors. That is why worldwide we have relatively only a limited number of publications on their occurrence. In our article, we tried to collect these studies from different continents so that we could get a concise, relevant picture of their epidemiology. For our research, we have looked for publications in PubMed between 1998 and 2018 and we systematized the results. Benign tumors occurred at a higher rate, on average 65,6%, 34,4% of malignancies, except Nigeria and Iran, where malignant tumors were more common. The average age is 46,8 years, in Europe the age group of 50s, on other continents the age group of 40s is more concerned. The gender distribution is equal, except in Mexico, Cameroon and Tehran, where female dominance is significant. Most tumors were localized in the parotid, the most common benign tumor was pleomorphic adenoma, while adenocystic carcinoma and mucoepidermoid carcinoma ranked first among malignants. Differences in countries around the world can be attributed to geographical, ethnic and social reasons, and to differences in health administration and registration. Further investigations are needed to identify the causes more accurately.

Keywords: benign and malignant salivary gland tumors, epidemiology

Review